Form 4 for AMLX Amylyx Pharmaceuticals, Inc.
Accepted 2022-02-28 00:00:00 ET · period of report 2022-02-22 · accession 0000899243-22-008101 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-28 | 2022-02-22 | AMLX | Mazzariello Gina | CLO | A - Grant | $0.00 | +41.0K | 41.0K | New | $0 |
| D | 2022-02-28 | 2022-02-22 | AMLX | Mazzariello Gina | CLO | A - Grant | $0.00 | +182.0K | 182.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-22 | A | A | 41,000 | $0.00 | 41,000 | D | — | — | (F1) The reported transaction involves the Reporting Person's receipt of a restricted stock unit award (a "RSU"). The RSU shall vest in 4 equal annual installments, with the first installment vesting on the one year anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date. |
| 2 | Derivative | Stock Option (right to buy) | 2022-02-22 | A | A | 182,000 | $0.00 | 182,000 | D | $28.24 · — to 2032-02-22 | 182,000 Common Stock | (F2) 1/4 of the shares subject to the option shall vest and become exercisable on the one year anniversary of the date of grant, and the remaining shares shall vest 1/48 monthly over the 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer through such vesting date. |